STOCK TITAN

[Form 4] USANA HEALTH SCIENCES INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

USANA Health Sciences (USNA) reported an insider transaction by a director on 10/23/2025. The filing shows the conversion of restricted stock units into 1,057 shares of common stock (Transaction Code M) and a separate Code F disposition of 265 shares at $20.63 per share.

Following these transactions, the reporting person directly held 9,027 shares of common stock and 2,115 restricted stock units. The RSUs vest in four 25% installments on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

USANA Health Sciences (USNA) ha riportato una transazione interna da parte di un direttore il 23/10/2025. La documentazione mostra la conversione di unità azionarie limitate in 1.057 azioni ordinarie (Transazione Codice M) e una separata disposizione Codice F di 265 azioni a $20,63 per azione.

Dopo queste transazioni, la persona che ha presentato il rapporto deteneva direttamente 9.027 azioni ordinarie e 2.115 unità azionarie limitate. Le RSU maturano in quattro rate del 25% ciascuna il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026.

USANA Health Sciences (USNA) informó una transacción interna por parte de un directivo el 23/10/2025. El registro muestra la conversión de unidades de acciones restringidas en 1.057 acciones ordinarias (Código de Transacción M) y una disposición separada Código F de 265 acciones a $20.63 por acción.

Después de estas transacciones, la persona que presentó el informe poseía directamente 9.027 acciones ordinarias y 2.115 unidades de acciones restringidas. Las RSU se consolidan en cuatro cuotas del 25% cada una el 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026.

USANA Health Sciences (USNA) 이사회 임원이 2025년 10월 23일 insider 거래를 보고했습니다. 공시에는 제한 주식 단위의 1,057주의 일반주식으로의 전환(Transaction Code M)과 별도의 Code F 처분으로 265주가 주당 $20.63에 매각된 내용이 나와 있습니다.

이 거래 이후 보고자는 일반주식 9,027주2,115주로 분류된 RSU를 직접 보유하고 있습니다. RSU는 4회에 걸쳐 각각 25% 비율로 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일에 vest됩니다.

USANA Health Sciences (USNA) a annoncé une opération interne par un administrateur le 23/10/2025. Le dépôt montre la conversion d’unités d’actions restreintes en 1 057 actions ordinaires (Code de transaction M) et une disposition séparée Code F de 265 actions à $20,63 par action.

Après ces transactions, la personne déclarante détenait directement 9 027 actions ordinaires et 2 115 unités d’actions restreintes. Les RSU se vestent en quatre tranches de 25% chacun les 24 juillet 2025, 23 octobre 2025, 22 janvier 2026 et 23 avril 2026.

USANA Health Sciences (USNA) meldete eine Insider-Transaktion durch einen Direktor am 23.10.2025. Die Einreichung zeigt die Umwandlung von Restricted Stock Units in 1.057 Stammaktien (Transaktionscode M) sowie eine separate Code F-Veräußerung von 265 Aktien zu je $20,63 pro Aktie.

Nach diesen Transaktionen hielt die meldende Person direkt 9.027 Aktien und 2.115 RSUs. Die RSUs vesten in vier 25%-Raten am 24. Juli 2025, 23. Oktober 2025, 22. Januar 2026 und 23. April 2026.

USANA Health Sciences (USNA) أبلغت عن صفقة داخلية من قبل مدير في 23/10/2025. يظهر الإبلاغ تحويل وحدات الأسهم المقيدة إلى 1,057 سهماً عادياً (رمز المعاملة M) وتصرّف منفصل رمز F من 265 سهماً بسعر $20.63 للسهم الواحد.

بعد هذه الصفقة، كان الشخص المبلغ عنه يمتلك مباشرة 9,027 سهماً عادياً و2,115 وحدة أسهم مقيدة. تأتي RSU vest كإحالة إلى أربع دفعات كل منها 25% في 24 يوليو 2025، 23 أكتوبر 2025، 22 يناير 2026، و23 أبريل 2026.

Positive
  • None.
Negative
  • None.

USANA Health Sciences (USNA) ha riportato una transazione interna da parte di un direttore il 23/10/2025. La documentazione mostra la conversione di unità azionarie limitate in 1.057 azioni ordinarie (Transazione Codice M) e una separata disposizione Codice F di 265 azioni a $20,63 per azione.

Dopo queste transazioni, la persona che ha presentato il rapporto deteneva direttamente 9.027 azioni ordinarie e 2.115 unità azionarie limitate. Le RSU maturano in quattro rate del 25% ciascuna il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026.

USANA Health Sciences (USNA) informó una transacción interna por parte de un directivo el 23/10/2025. El registro muestra la conversión de unidades de acciones restringidas en 1.057 acciones ordinarias (Código de Transacción M) y una disposición separada Código F de 265 acciones a $20.63 por acción.

Después de estas transacciones, la persona que presentó el informe poseía directamente 9.027 acciones ordinarias y 2.115 unidades de acciones restringidas. Las RSU se consolidan en cuatro cuotas del 25% cada una el 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026.

USANA Health Sciences (USNA) 이사회 임원이 2025년 10월 23일 insider 거래를 보고했습니다. 공시에는 제한 주식 단위의 1,057주의 일반주식으로의 전환(Transaction Code M)과 별도의 Code F 처분으로 265주가 주당 $20.63에 매각된 내용이 나와 있습니다.

이 거래 이후 보고자는 일반주식 9,027주2,115주로 분류된 RSU를 직접 보유하고 있습니다. RSU는 4회에 걸쳐 각각 25% 비율로 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일에 vest됩니다.

USANA Health Sciences (USNA) a annoncé une opération interne par un administrateur le 23/10/2025. Le dépôt montre la conversion d’unités d’actions restreintes en 1 057 actions ordinaires (Code de transaction M) et une disposition séparée Code F de 265 actions à $20,63 par action.

Après ces transactions, la personne déclarante détenait directement 9 027 actions ordinaires et 2 115 unités d’actions restreintes. Les RSU se vestent en quatre tranches de 25% chacun les 24 juillet 2025, 23 octobre 2025, 22 janvier 2026 et 23 avril 2026.

USANA Health Sciences (USNA) meldete eine Insider-Transaktion durch einen Direktor am 23.10.2025. Die Einreichung zeigt die Umwandlung von Restricted Stock Units in 1.057 Stammaktien (Transaktionscode M) sowie eine separate Code F-Veräußerung von 265 Aktien zu je $20,63 pro Aktie.

Nach diesen Transaktionen hielt die meldende Person direkt 9.027 Aktien und 2.115 RSUs. Die RSUs vesten in vier 25%-Raten am 24. Juli 2025, 23. Oktober 2025, 22. Januar 2026 und 23. April 2026.

USANA Health Sciences (USNA) أبلغت عن صفقة داخلية من قبل مدير في 23/10/2025. يظهر الإبلاغ تحويل وحدات الأسهم المقيدة إلى 1,057 سهماً عادياً (رمز المعاملة M) وتصرّف منفصل رمز F من 265 سهماً بسعر $20.63 للسهم الواحد.

بعد هذه الصفقة، كان الشخص المبلغ عنه يمتلك مباشرة 9,027 سهماً عادياً و2,115 وحدة أسهم مقيدة. تأتي RSU vest كإحالة إلى أربع دفعات كل منها 25% في 24 يوليو 2025، 23 أكتوبر 2025، 22 يناير 2026، و23 أبريل 2026.

USANA Health Sciences (USNA) 披露了一名董事的内部交易,日期为2025/10/23。该披露显示将受限股票单位转换为1,057股普通股(交易代码M),以及另一项代码F处置,共265股,每股价格为$20.63

在这些交易之后,报告人直接持有9,027股普通股和2,115股受限股票单位。RSU 将分四次于2025年7月24日2025年10月23日2026年1月22日2026年4月23日分别归属(vest)25%。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WOOD TIMOTHY E

(Last) (First) (Middle)
3838 WEST PARKWAY BLVD

(Street)
SALT LAKE CITY UT 84120

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/23/2025 M 1,057 A (1) 9,292 D
Common Stock 10/23/2025 F 265 D $20.63 9,027 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/23/2025 M 1,057 (2) (2) Common Stock 1,057 $0 2,115 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did USANA (USNA) report?

A director reported RSU conversion into 1,057 shares (Code M) and a separate Code F disposition of 265 shares at $20.63 on 10/23/2025.

How many USANA shares are held after the transactions?

The reporting person directly held 9,027 shares of common stock after the reported transactions.

How many RSUs remain after the USANA transactions?

The filing lists 2,115 restricted stock units beneficially owned following the transactions.

What were the transaction codes used in the USANA Form 4?

The filing shows Code M for the RSU conversion and Code F for the share disposition.

What is the vesting schedule for the USANA RSUs?

RSUs vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

At what price were shares disposed in the Code F transaction?

The disposition price reported was $20.63 per share.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

358.31M
10.40M
42.93%
61.22%
3.86%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY